Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ONCE
Delisted

Spark Therapeutics Stock Price (Quote)

$113.57
+0 (+0%)
At Close: Jan 24, 2020

Range Low Price High Price Comment
30 days $113.57 $113.57 Friday, 24th Jan 2020 ONCE stock ended at $113.57. During the day the stock fluctuated 0% from a day low at $113.57 to a day high of $113.57.
90 days $108.00 $113.90
52 weeks $40.64 $114.20

Historical Spark Therapeutics prices

Date Open High Low Close Volume
Aug 30, 2019 $99.53 $99.99 $96.90 $97.41 801 780
Aug 29, 2019 $100.11 $101.20 $98.45 $99.74 468 616
Aug 28, 2019 $99.20 $99.93 $98.61 $99.42 320 105
Aug 27, 2019 $99.32 $100.55 $98.54 $99.62 348 628
Aug 26, 2019 $101.28 $101.62 $98.00 $99.25 252 553
Aug 23, 2019 $101.49 $101.88 $100.58 $100.78 416 989
Aug 22, 2019 $101.50 $101.74 $100.52 $101.25 162 514
Aug 21, 2019 $101.40 $101.50 $100.84 $101.27 172 582
Aug 20, 2019 $100.29 $101.47 $100.29 $100.85 147 992
Aug 19, 2019 $101.21 $101.46 $99.63 $101.02 220 828
Aug 16, 2019 $100.91 $101.24 $99.25 $100.57 159 100
Aug 15, 2019 $98.67 $100.31 $98.00 $100.11 196 272
Aug 14, 2019 $97.93 $99.25 $96.55 $98.82 358 962
Aug 13, 2019 $97.11 $99.12 $97.11 $98.92 155 495
Aug 12, 2019 $100.40 $100.40 $97.08 $97.25 356 565
Aug 09, 2019 $101.00 $101.90 $100.05 $100.83 163 521
Aug 08, 2019 $101.96 $101.99 $100.24 $101.78 156 487
Aug 07, 2019 $101.79 $101.91 $99.90 $100.73 155 842
Aug 06, 2019 $101.65 $102.05 $100.30 $101.04 157 660
Aug 05, 2019 $100.90 $101.73 $100.02 $101.32 254 011
Aug 02, 2019 $102.12 $102.42 $100.43 $101.53 383 674
Aug 01, 2019 $100.20 $103.68 $99.63 $102.60 727 571
Jul 31, 2019 $99.49 $100.49 $98.57 $100.02 402 533
Jul 30, 2019 $98.26 $99.32 $98.26 $99.23 332 508
Jul 29, 2019 $98.16 $99.12 $97.23 $98.67 400 478
Click to get the best stock tips daily for free!

About Spark Therapeutics

Spark Therapeutics Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. The company develops SPK-RPE65, which is in Phase III clinical trial for the treatment of genetic blinding conditions called inherited retinal diseases caused by non sex-linked, autosomal recessive, or mutations in the RPE65 gene; and SPK-CHM that is in Phase I/II clinical trial for the treatment of choroideremia... ONCE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT